Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Registrational Study With Omecamtiv Mecarbil/AMG 423 to Treat Chronic Heart Failure With Reduced Ejection Fraction (GALACTIC-HF)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02929329
Recruitment Status : Active, not recruiting
First Posted : October 11, 2016
Last Update Posted : July 17, 2019
Sponsor:
Collaborators:
Cytokinetics
Servier
Information provided by (Responsible Party):
Amgen

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : February 7, 2021
Estimated Study Completion Date : February 7, 2021